CJ Bioscience, Inc. (KOSDAQ: A311690)
Health Care · Health Care Technology · KR
₩3,695.00
-7.04% today · -61.3% 1Y
CJ Bioscience, Inc. (KOSDAQ: A311690) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $34.83M.
Over the last twelve months the share price has lost 61.3%, trading between 3.06K and 10.43K.
Tweenvest scores CJ Bioscience, Inc. across four factors: quality 28/100, value 41/100. Its strongest factor is value.
A311690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.83M
- Revenue (TTM)
- $2.34M
- P/E
- —
- EPS
- -1,760.74
- Dividend yield
- —
- Beta (5Y)
- 0.51
- 52-week high
- ₩10,430.00
- 52-week low
- ₩3,060.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.07M
- Employees
- —
- Next earnings
- —
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.36B | $245.67 | -1.12% |
| Pro Medicus LimitedASX: PME | $14.46B | AU$193.43 | +0.96% |
| M3, Inc.TSE: 2413 | $7.21B | ¥1,719.50 | +0.67% |
| Sectra AB (publ)OM: SECT B | $5.60B | Skr275.80 | -0.79% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.86B | $25.14 | -0.83% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $24.75 | -2.17% |
| HeartFlow, Inc.NasdaqGS: HTFL | $4.37B | $50.15 | -0.10% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.